Le Lézard
Classified in: Ebola virus, Science and technology
Subject: ACC

Sandvik - Interim Report Third Quarter 2017



SANDVIKEN, Sweden, Oct. 24, 2017 /PRNewswire/ --

Continuing operations  

Discontinued operations

Group Total

Additional information may be obtained from Sandvik Investor Relations, 
phone +46-8-456-14-94 (Ann-Sofie Nordh),
+46-8-456-11-94 (Anna Vilogorac) or
e-mailing info.ir@sandvik.com

A presentation and teleconference will be held on 24 October 2017 at 15:00 CET. Information is available at home.sandvik/investor 

Stockholm, 24 October 2017

Sandvik Aktiebolag (publ)

Björn Rosengren
President and CEO

This information is information that Sandvik AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at about 13.30 CET on 24 October 2017.This information was brought to you by Cision http://news.cision.com 

http://news.cision.com/sandvik/r/interim-report-third-quarter-2017,c2374344

The following files are available for download:

http://mb.cision.com/Main/208/2374344/740793.pdf

Interim Report Third Quarter 2017


These press releases may also interest you

20 sep 2018
Merck , known as MSD outside the United States and Canada, today issued its 2017/2018 global Corporate Responsibility Report. The report reflects the company's performance and progress in its four corporate responsibility priority areas of Access to...

19 sep 2018
The "Heterogeneous Networks (HetNets) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. This report analyzes the worldwide markets for Heterogeneous Networks (HetNets) in US$ Million for major Geographic...

19 sep 2018
The "Dental Infection Control Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

18 sep 2018
The "Global Anti-infective Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering. The global...

18 sep 2018
Aethlon Medical, Inc. , a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the Company a government grant (number 1R43CA232977-01). The title...

17 sep 2018
Tru-D SmartUVC, a leader in the UVC disinfection space, will attend and exhibit at the 2018 AHE Exchange, September 23-26 in Columbus, Ohio. Tru-D invites attendees to its booth #623 to learn how the UVC disinfection robot can help prevent...




News published on 24 october 2017 at 08:06 and distributed by: